Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
NEWAMSTERDAM PHARMA COMPANY
Ticker: NAMS
CUSIP: N62509109
Class: Stock
Brinker Capital Investments, LLC's Holding History (CIK: 0001360533)
Note: Option positions (PUT/CALL) are excluded.
Q4 2025
Shares
6,545
Value ($000)
$230
Avg Close
$36.39
Range
$28.19 - $42.00
Period
Shares
Value ($000)
Average Close
Price Range
Q4 2025
6,545
$230
$36.39
$28.19 - $42.00